Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
SHetA2
Description:
An experimental orally bioavailable anticancer compound studied for its pharmacokinetics, pharmacodynamics, and effects on tumor cells.
Related topics:
Heat shock proteins research (12%),
Cell death mechanisms and regulation (11%),
Heterocyclic Compound Synthesis and Bioactivity (11%),
Cancer-related Molecular Pathways (7%)
OpenAlex ID:
keywords/sheta2
Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells
2009
·
Chioniso Patience Masamha
, Doris Mangiaracina Benbrook
·
Cancer Research
·
224
The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway.
2003
·
Kyung-Hee Chun
, Doris M Benbrook
, et al.
·
PubMed
·
58
Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells
2008
·
Yidan Lin
, Xiangguo Liu
, et al.
·
Molecular Cancer Therapeutics
·
51
CAAT/Enhancer Binding Protein Homologous Protein–Dependent Death Receptor 5 Induction Is a Major Component of SHetA2-Induced Apoptosis in Lung Cancer Cells
2008
·
Yi-Dan Lin
, Shuzhen Chen
, et al.
·
Cancer Research
·
50
SHetA2 interference with mortalin binding to p66shc and p53 identified using drug-conjugated magnetic microspheres
2013
·
Doris Mangiaracina Benbrook
, Baskar Nammalwar
, et al.
·
Investigational New Drugs
·
45
PDF
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53
2020
·
Satish K. Ramraj
, Sugantha P. Elayapillai
, et al.
·
International Journal of Cancer
·
44
Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs
2012
·
Kasim K. Kabirov
, Izet M. Kapetanovic
, et al.
·
Drug and Chemical Toxicology
·
41
Development of flexible-heteroarotinoids for kidney cancer
2009
·
Tongzu Liu
, Chioniso Patience Masamha
, et al.
·
Molecular Cancer Therapeutics
·
40
Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCmin/+ Mice By SHetA2 (NSC721689) without Toxicity
2013
·
Doris Mangiaracina Benbrook
, Suresh Guruswamy
, et al.
·
Cancer Prevention Research
·
33
Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo
2008
·
Tashanna Myers
, Shylet Chengedza
, et al.
·
Investigational New Drugs
·
32
PDF
Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen
2012
·
Rupa S. Doppalapudi
, Edward S. Riccio
, et al.
·
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
·
31
Gene Expression Analysis of Biological Systems Driving an Organotypic Model of Endometrial Carcinogenesis and Chemoprevention
2008
·
Doris M. Benbrook
, Stan Lightfoot
, et al.
·
Gene Regulation and Systems Biology
·
28
PDF
Metabolism of a sulfur‐containing heteroarotionoid antitumor agent, SHetA2, using liquid chromatography/tandem mass spectrometry
2008
·
Zhongfa Liu
, Yilong Zhang
, et al.
·
Rapid Communications in Mass Spectrometry
·
26
High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2
2006
·
Yilong Zhang
, Yousheng Hua
, et al.
·
Cancer Chemotherapy and Pharmacology
·
26
SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention
2022
·
Doris Mangiaracina Benbrook
·
Frontiers in Cell and Developmental Biology
·
25
PDF
Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents
2015
·
Shengquan Liu
, Maggie C. Louie
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
23
Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
2021
·
Vishal Chandra
, Rajani Rai
, et al.
·
Cancers
·
22
Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents
2009
·
Katherine Marie Moxley
, Shylet Chengedza
, et al.
·
Gynecologic Oncology
·
21
Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2
2018
·
Ankur Sharma
, Doris Mangiaracina Benbrook
, et al.
·
PLoS ONE
·
20
PDF
NF-κB is involved in SHetA2 circumvention of TNF-α resistance, but not induction of intrinsic apoptosis
2010
·
Shylet Chengedza
, Doris Mangiaracina Benbrook
·
Anti-Cancer Drugs
·
20
Heteroarotinoids with Anti-Cancer Activity Against Ovarian Cancer Cells
2007
·
Thanh C. Le
, K. Darrell Berlin
, et al.
·
The Open Medicinal Chemistry Journal
·
20
PDF
Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia
2017
·
Sanjida Mahjabeen
, Manolya K. Hatipoglu
, et al.
·
Journal of Pharmaceutical Sciences
·
18
Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2
2018
·
Field M. Watts
, Tim Pouland
, et al.
·
European Journal of Medicinal Chemistry
·
17
The Peptidomimetic, 1-Adamantyl-Substituted, and Flex-Het Classes of Retinoid-Derived Molecules: Their Structure-Activity Relationships and Retinoid Receptor-Independent Anticancer Activities
2010
·
M.I. Dawson
, J.A. Fontana
·
Mini-Reviews in Medicinal Chemistry
·
16
Influence of the estrus cycle of the mouse on the disposition of SHetA2 after vaginal administration
2018
·
Sanjida Mahjabeen
, Manolya Kukut Hatipoglu
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
15
PDF
Show more works
View as search
Works count:
108
Citation count:
1,149
Year
Topic
Type